Skip to content

Homburg Cream & Sugar Study

Prospective Investigation of the Influence of Triglyceride Tolerance on Cardiovascular Outcomes in Patients With Coronary Artery Disease

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00628524
Acronym
HCS
Enrollment
514
Registered
2008-03-05
Start date
2008-02-29
Completion date
2013-08-31
Last updated
2025-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Disease, Diabetes, Glucose Tolerance, Hyperlipidemia, Metabolic Syndrome

Brief summary

The purpose of this study is to prospectivly analyze the correlation of triglyceride tolerance and glucose tolerance with cardiovascular morbidity and mortality in patients with stable coronary artery disease within 18 months and to determine, whether measurement of triglyceride tolerance can discriminate patients at risk for cardiovascular events.

Interventions

None listed

Sponsors

Universität des Saarlandes
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Stable CAD

Exclusion criteria

* Acute Coronary Syndrom * Relevant Arrhythmias * Severe valvular heart disease * Decompensated heart failure * Severe inflammtory disease (infectious, rheumatoid) * Metabolic diseases (e.g. thyroid) * Inability to swallow * Liver or kidney failure * Lactose intolerance * Fat intolerance (e.g. chronic pancreatitis, gall stones) * Malignant Disease * Psychiatric Diseases (including alcohol / drug abuse) * Pregnancy

Design outcomes

Primary

MeasureTime frame
Parameters of triglyceride tolerance and glucose tolerance in correlation to cardiovascular events, cardiovascular mortality, total mortality.48 months after inclusion.

Secondary

MeasureTime frame
Waist-to-Hip ratio, nutrition protocol, physical activity, non-invasive endothelial function, body fat composition, other biomarkers of lipid and glucose metabolism.Directly after inclusion.

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 19, 2026